Intervention Protocol

Alterations in parenteral nutrition management for the treatment of parenteral nutrition-associated cholestasis in term and preterm infants

  1. James I Hagadorn1,*,
  2. Leslie Wolkoff2,
  3. Patricia Esposito2,
  4. Heather L Brumberg3,
  5. Karan Emerick4,
  6. James R Gerace2

Editorial Group: Cochrane Neonatal Group

Published Online: 15 APR 2009

Assessed as up-to-date: 17 FEB 2009

DOI: 10.1002/14651858.CD007833

Database Title

Additional Information

How to Cite

Hagadorn JI, Wolkoff L, Esposito P, Brumberg HL, Emerick K, Gerace JR. Alterations in parenteral nutrition management for the treatment of parenteral nutrition-associated cholestasis in term and preterm infants (Protocol). Cochrane Database of Systematic Reviews 2009, Issue 2. Art. No.: CD007833. DOI: 10.1002/14651858.CD007833.

Author Information

  1. 1

    University of Connecticut School of Medicine, Division of Neonatology, Hartford, Connecticut, USA

  2. 2

    Connecticut Children's Medical Center, Division of Neonatology, Hartford, Connecticut, USA

  3. 3

    New York Medical College-Westchester Medical Center, Division of Newborn Medicine, Valhalla, NY, USA

  4. 4

    Connecticut Children's Medical Center, Division of Gastroenterology, Hartford, Connecticut, USA

*James I Hagadorn, Division of Neonatology, University of Connecticut School of Medicine, Connecticut Childreh's Medical Center, 282 Washington Street, Hartford, Connecticut, 06106, USA. jhagadorn@ccmckids.org.

Publication History

  1. Publication Status: New
  2. Published Online: 15 APR 2009

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Full (139K)
 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the benefits and risks of alterations in PN components or PN administration for parenteral nutrition-associated cholestasis in term and preterm infants. Such alterations will include but not be limited to addition or elimination of specific PN components, increases or decreases in concentration of specific PN components, or changes in method of PN administration.

View Full Article (HTML) Full (139K)